首页> 美国卫生研究院文献>Cancer Biology Medicine >Research progress on the anticarcinogenic actions and mechanisms of ellagic acid
【2h】

Research progress on the anticarcinogenic actions and mechanisms of ellagic acid

机译:鞣花酸的抗癌作用及其机理研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer is a leading cause of death worldwide. Cancer treatments by chemotherapeutic agents, surgery, and radiation have not been highly effective in reducing the incidence of cancers and increasing the survival rate of cancer patients. In recent years, plant-derived compounds have attracted considerable attention as alternative cancer remedies for enhancing cancer prevention and treatment because of their low toxicities, low costs, and low side effects. Ellagic acid (EA) is a natural phenolic constituent. Recent in vitro and in vivo experiments have revealed that EA elicits anticarcinogenic effects by inhibiting tumor cell proliferation, inducing apoptosis, breaking DNA binding to carcinogens, blocking virus infection, and disturbing inflammation, angiogenesis, and drug-resistance processes required for tumor growth and metastasis. This review enumerates the anticarcinogenic actions and mechanisms of EA. It also discusses future directions on the applications of EA.
机译:癌症是全球主要的死亡原因。通过化学治疗剂,手术和放射线进行的癌症治疗在降低癌症的发生率和增加癌症患者的存活率方面不是非常有效的。近年来,植物来源的化合物由于其低毒性,低成本和低副作用而作为用于增强癌症预防和治疗的替代癌症疗法引起了相当大的关注。鞣花酸(EA)是天然的酚类成分。最近的体外和体内实验表明,EA通过抑制肿瘤细胞增殖,诱导凋亡,破坏与致癌物的DNA结合,阻断病毒感染以及扰乱肿瘤生长和转移所需的炎症,血管生成和耐药过程,从而引发抗癌作用。 。这篇综述列举了EA的抗癌作用和机理。它还讨论了EA应用的未来方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号